前往化源商城

Neurotherapeutics 2007-01-01

Ganaxolone.

Virinder Nohria, Earl Giller

文献索引:Neurotherapeutics 4(1) , 102-5, (2007)

全文:HTML全文

摘要

Ganaxolone (3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one) (GNX) is the 3beta-methylated synthetic analog of allopregnanolone; it belongs to a class of compounds referred to as neurosteroids. GNX is an allosteric modulator of GABA(A) receptors acting through binding sites which are distinct from the benzodiazepine binding site. It has activity in a broad range of animal models of epilepsy. GNX has been shown to be well tolerated in adults and children. In early phase II studies, GNX has been shown to have activity in adult patients with partial-onset seizures and epileptic children with history of infantile spasms. It is currently undergoing further development in infants with newly diagnosed infantile spasms, in women with catamenial epilepsy, and in adults with refractory partial-onset seizures.

相关化合物

结构式 名称/CAS号 全部文献
加奈索酮 结构式 加奈索酮
CAS:38398-32-2